Hsp90 drug targeting in bladder cancer cells

被引：0
|
作者：
Karkoulis, P. K. [1 ]
Stravopodis, D. J. [2 ]
Konstantakou, E. G. [2 ]
Melachroinou, S. [1 ]
Anastasiou, D. [1 ]
Margaritis, L. H. [2 ]
Voutsinas, G. E. [1 ]
机构：
[1] NCSR Demokritos, Inst Biol, Lab Environm Mutagenesis & Carcinogenesis, Athens 15310, Greece
[2] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens 15784, Greece
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
207
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] A new HSP90 inhibitor as therapeutic agent for bladder cancer.
    Liu, Weiya
    Lee, Eugene K.
    Pirani, Karim
    Blagg, Brian S. J.
    Holzbeierlein, Jeffrey M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [32] Selective targeting of cancer cells using a hydrogen peroxide-activated Hsp90 inhibitor
    Oh, Yong Jin
    Park, Sun You
    Seo, Young Ho
    BIOORGANIC CHEMISTRY, 2021, 115
  • [33] Targeting Hsp90 prevents escape of breast cancer cells from tyrosine kinase inhibition
    Pashtan, Itai
    Tsutsumi, Shinji
    Wang, Suiquan
    Xu, Wanping
    Neckers, Len
    CELL CYCLE, 2008, 7 (18) : 2936 - 2941
  • [34] AICAR: A rational identified small molecule targeting Hsp90 chaperone function in cancer cells
    Pennati, M.
    Meli, M.
    Curto, M.
    Daidone, M. G.
    Plescia, J.
    Toba, S.
    Altieri, D. C.
    Zaffaroni, N.
    Colombo, G.
    EJC SUPPLEMENTS, 2006, 4 (12): : 110 - 110
  • [35] Targeting HSP90 in Gynecologic Cancer: Molecular Mechanisms and Therapeutic Approaches
    Min, Lu
    Li, Xuewei
    Liang, Lily
    Ruan, Zheng
    Yu, Shaohui
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2025, 83 (01) : 177 - 192
  • [36] Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects
    Liang, Xinqi
    Chen, Ruixian
    Wang, Chengdi
    Wang, Yuxi
    Zhang, Jifa
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (18) : 15968 - 15995
  • [37] Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90
    Fadden, Patrick
    Huang, Kenneth H.
    Veal, James M.
    Steed, Paul M.
    Barabasz, Amy F.
    Foley, Briana
    Hu, Mei
    Partridge, Jeffrey M.
    Rice, John
    Scott, Anisa
    Dubois, Laura G.
    Freed, Tiffany A.
    Silinski, Melanie A. Rehder
    Barta, Thomas E.
    Hughes, Philip F.
    Ommen, Andy
    Ma, Wei
    Smith, Emilie D.
    Spangenberg, Angela Woodward
    Eaves, Jeron
    Hanson, Gunnar J.
    Hinkley, Lindsay
    Jenks, Matthew
    Lewis, Meredith
    Otto, James
    Pronk, Gijsbertus J.
    Verleysen, Kathleen
    Haystead, Timothy A.
    Hall, Steven E.
    CHEMISTRY & BIOLOGY, 2010, 17 (07): : 686 - 694
  • [38] Strategies for Stalling Malignancy: Targeting Cancer's Addiction to Hsp90
    Prodromou, Chrisostomos
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (15) : 1352 - 1368
  • [39] Structure-based drug design targeting Plasmodium falciparum hsp90
    Pillai, Dylan R.
    Corbett, Kevin C.
    Anderson, Marc O.
    DeRisi, Joseph L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 97 - 97
  • [40] Therapeutic Targeting of HSP90 in AML and ALL
    Bhatia, Sanil
    Ahlert, Heinz
    Frieg, Benedikt
    Borkhardt, Arndt
    Gohlke, Holger
    Kurz, Thomas
    Hauer, Julia
    BLOOD, 2018, 132
12345